Hyderabad Telangana, India

Bhavesh Vallabhbhai Patel

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Bhavesh Vallabhbhai Patel: Innovator in Pharmaceutical Formulations

Introduction

Bhavesh Vallabhbhai Patel is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid formulations for cancer treatment. With a total of three patents to his name, Patel's work is recognized for its potential impact on patient care.

Latest Patents

Patel's latest patents focus on stable liquid formulations of cyclophosphamide. These formulations comprise cyclophosphamide and at least one pharmaceutically acceptable excipient, with a moisture content of less than about 2.0% by weight. The invention outlines a process for reducing moisture content from cyclophosphamide or its liquid compositions. Furthermore, it details methods for using these stable formulations for parenteral administration, either as ready-to-use or ready-to-dilute options for treating various cancer disorders.

Career Highlights

Throughout his career, Bhavesh Vallabhbhai Patel has worked with prominent companies in the pharmaceutical industry. He has been associated with Dr. Reddy's Laboratories and Avyxa Holdings, where he has contributed to innovative research and development efforts. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the field.

Collaborations

Patel has collaborated with several professionals in his field, including Riyaz Ahmed Shaik and Ananya Saha. These collaborations have likely enhanced his research and development capabilities, leading to successful innovations.

Conclusion

Bhavesh Vallabhbhai Patel is a distinguished inventor whose work in stable liquid formulations of cyclophosphamide has the potential to improve cancer treatment options. His contributions to the pharmaceutical industry reflect his commitment to innovation and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…